No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Age Factors
-
Aged
-
Aged, 80 and over
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cyclophosphamide / therapeutic use
-
Doxorubicin / therapeutic use
-
Female
-
Humans
-
Lymphoma, Follicular / genetics*
-
Lymphoma, Follicular / mortality
-
Lymphoma, Follicular / therapy*
-
Male
-
Middle Aged
-
Mutation*
-
Prednisone / therapeutic use
-
Rituximab
-
Survival Analysis
-
Treatment Outcome
-
Vincristine / therapeutic use
-
Young Adult
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
R-CHOP protocol
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone